We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Gastric Cancer Foundation: A Gastric Cancer Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01514045
Recruitment Status : Recruiting
First Posted : January 20, 2012
Last Update Posted : August 10, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer via an online questionnaire with genomic data obtained from blood and tissue samples. The purpose of this registry is to gain better understanding of the causes of gastric cancer, both environmental and genetic; whether certain genomic data can predict outcomes of treatment and survival; as well as explore the issues that effect the quality of life of these patients after diagnosis and treatment.

Condition or disease
Gastric Cancer

Detailed Description:
Collect detailed clinical and epidemiological information on patients with gastric tumors via an online registry and a detailed patient questionnaire. Participants can opt in to contribute a blood sample and paraffin block samples from previous surgery.

Study Design

Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: The Gastric Cancer Foundation: A Gastric Cancer Registry
Study Start Date : April 2011
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Stomach Cancer
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Collect detailed clinical and epidemiological information on patients with gastric tumors [ Time Frame: A quality of life questionnaire will also be administered when patients first enroll in the registry and then every 6 months after for five years. Specimen collected once. ]

Biospecimen Retention:   Samples With DNA
Blood samples with DNA Paraffin embedded tissue will be stored in the Stanford Tissue Bank for 100 years.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants will be identified for recruitment either by the individual's treating physician or through information about the registry on the Gastric Cancer Fund website. Potential participants will be directed to the URL for the gastric cancer registry and asked to complete a brief registration form which will include eligibility questions.
Criteria

Inclusion Criteria:

  1. Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors
  2. 18 years of age or older
  3. Adequate English proficiency to complete online consent and questionnaire.

Exclusion Criteria:

  1. Under 18 years of age
  2. No history of gastric cancer or gastric cancer in a family member.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01514045


Contacts
Contact: Meredith Mills 650-724-5223 bluett@stanford.edu

Locations
United States, California
Stanford University, School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Meredith Mills    650-724-5223    bluett@stanford.edu   
Principal Investigator: James M Ford, MD         
Sub-Investigator: Hanlee P Ji, MD         
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: James M Ford, MD Stanford University
More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01514045     History of Changes
Other Study ID Numbers: GI0005
SU-01172012-8987 ( Other Identifier: Stanford University )
20285 ( Other Identifier: Stanford University )
First Posted: January 20, 2012    Key Record Dates
Last Update Posted: August 10, 2017
Last Verified: August 2017

Keywords provided by Stanford University:
Quality of Life

Additional relevant MeSH terms:
Stomach Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases